• LAST PRICE
    0.8499
  • TODAY'S CHANGE (%)
    Trending Up0.0599 (7.5823%)
  • Bid / Lots
    0.8650/ 9
  • Ask / Lots
    0.8985/ 1
  • Open / Previous Close
    0.8500 / 0.7900
  • Day Range
    Low 0.8000
    High 0.8860
  • 52 Week Range
    Low 0.6640
    High 5.0699
  • Volume
    372,291
    average

Search Criteria

Filter search criteria using below inputs

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
CompanyCountrySymbol

TD Direct Investing offers more research reports than any other discount brokerage in Canada. Provided from the industry's most trusted sources, our service includes timely, relevant information for the current trading day and comprehensive industry, sector, and insider trading reports for further analysis.

Open a New Account, or Login if you're a client.

  • Yesterday

      Show headlines and story abstract
    • 10:49AM ET on Friday Oct 04, 2024 by MT Newswires
      Companies Mentioned: STIM
      10:49 AM EDT, 10/04/2024 (MT Newswires) -- Neuronetics (STIM) and Greenbrook TMS said Friday they have received an interim order from the Ontario Superior Court of Justice, authorizing Greenbrook to hold a special meeting of its shareholders on Nov....
    • 8:34AM ET on Friday Oct 04, 2024 by CNW Group
      Companies Mentioned: STIM

      COMTEX_458475731/2669/2024-10-04T08:34:30

    • 8:34AM ET on Friday Oct 04, 2024 by PR Newswire
      Companies Mentioned: STIM, GBNHF

      Neuronetics, Inc. (NASDAQ: STIM) ("Neuronetics") and Greenbrook TMS Inc. (OTCMKTS: GBNHF) ("Greenbrook") today announced that the Ontario Superior Court of Justice (Commercial List) (the "Court") has granted an interim order (the "Interim Order") in connection with the previously announced statutory plan of arrangement under section 182 of the Business Corporations Act (Ontario) (the "Plan of Arrangement"), pursuant to which, subject to the satisfaction or waiver of all applicable conditions precedent, Neuronetics will acquire all of the issued and outstanding common shares of Greenbrook ("Greenbrook Shares") in an all-stock transaction (the "Arrangement"). The Interim Order authorizes the calling and holding of a special meeting (the "Greenbrook Special Meeting") of holders of Greenbrook Shares ("Greenbrook Shareholders"), the granting of dissent rights to registered Greenbrook Shareholders and other matters relating to the conduct of the Greenbrook Special Meeting.

    • 8:34AM ET on Friday Oct 04, 2024 by Dow Jones
      Companies Mentioned: STIM, GBNHF

      operating results and business generally; (viii) the outcome of any legal proceedings related to the Arrangement; (ix) retention of employees of Greenbrook following the completion of the Arrangement; * the fact that Greenbrook's and Neuronetics' stock price may decline significantly if the Arrangement is not completed; and other factors described under the heading "Risk Factors" in the Joint Proxy Statement/Circular, Neuronetics' Annual Report on Form 10-K for the fiscal year ended December 31, 2023 and its Quarterly Report on Form 10-Q for the quarter ended June 30, 2024, and Greenbrook's Annual Report on Form 10-K for the fiscal year ended December 31, 2023 and its Quarterly Report on Form 10-Q for the quarter ended June 30, 2024, as each may be updated or supplemented by subsequent reports that Neuronetics has filed or files with the Securities and Exchange Commission (the "SEC") and Greenbrook has filed or files with the SEC and on SEDAR+. These forward-looking statements are based on expectations and assumptions as of the date of this press release. Except as required by law, Neuronetics and Greenbrook undertake no duty or obligation to update any forward-looking statements contained in this press release as a result of new information, future events, or changes in their expectations.
    • 8:33AM ET on Friday Oct 04, 2024 by Dow Jones
      Companies Mentioned: STIM, GBNHF

      operating results and business generally; (viii) the outcome of any legal proceedings related to the Arrangement; (ix) retention of employees of Greenbrook following the completion of the Arrangement; * the fact that Greenbrook's and Neuronetics' stock price may decline significantly if the Arrangement is not completed; and other factors described under the heading "Risk Factors" in the Joint Proxy Statement/Circular, Neuronetics' Annual Report on Form 10-K for the fiscal year ended December 31, 2023 and its Quarterly Report on Form 10-Q for the quarter ended June 30, 2024, and Greenbrook's Annual Report on Form 10-K for the fiscal year ended December 31, 2023 and its Quarterly Report on Form 10-Q for the quarter ended June 30, 2024, as each may be updated or supplemented by subsequent reports that Neuronetics has filed or files with the Securities and Exchange Commission (the "SEC") and Greenbrook has filed or files with the SEC and on SEDAR+. These forward-looking statements are based on expectations and assumptions as of the date of this press release. Except as required by law, Neuronetics and Greenbrook undertake no duty or obligation to update any forward-looking statements contained in this press release as a result of new information, future events, or changes in their expectations.

Peers Headlines